EFX vs ERNA · P/E 54, rev $5.68B vs P/E 0.0, rev $582.0K
Equifax Inc (EFX) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the EFX and ERNA stock pages for the full models.
Not investment advice.